BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Sep 27, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Pennvax-B: Completed Phase I enrollment

Inovio and the HIV Vaccine Trials Network completed enrollment of 48 healthy volunteers in the double-blind, placebo-controlled, U.S. Phase I HVTN-080 trial to...

Read the full 102 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >